COVID-19 : shaping a sicker, poorer, more violent, and unstable Western Hemisphere / / R. Evan Ellis |
Autore | Ellis Robert Evan |
Pubbl/distr/stampa | [Carlisle Barracks, Pa.] : , : Strategic Studies Institute, United States Army War College, , 2020 |
Descrizione fisica | 1 online resource (7 unnumbered pages) |
Soggetto topico |
COVID-19 (Disease) - Western Hemisphere
COVID-19 (Disease) - Economic aspects - Western Hemisphere Political stability - Western Hemisphere |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | COVID-19 |
Record Nr. | UNINA-9910713557103321 |
Ellis Robert Evan
![]() |
||
[Carlisle Barracks, Pa.] : , : Strategic Studies Institute, United States Army War College, , 2020 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
COVID-19 |
Autore | Mittal Neeraj |
Edizione | [1st ed.] |
Pubbl/distr/stampa | Sharjah : , : Bentham Science Publishers, , 2021 |
Descrizione fisica | 1 online resource (223 pages) |
Disciplina | 616.2414 |
Altri autori (Persone) |
BhadadaSanjay K
KatareO. P |
Soggetto topico |
COVID-19 (Disease) - Prevention
COVID-19 (Disease) - Economic aspects COVID-19 (Disease) - Social aspects COVID-19 Pandemic, 2020- |
Soggetto non controllato |
Communicable Diseases
Medical |
ISBN | 1-68108-808-8 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Foreword -- Preface -- List of Contributors -- Chapter 1 -- Sunishtha1, Govind Singh1 and Sanju Nanda1,* -- INTRODUCTION -- THE ATHENIAN PLAGUE -- PLAGUE OF JUSTINIAN -- THE BLACK DEATH -- SPANISH FLU -- AIDS -- SMALLPOX -- SARS -- SWINE FLU OR H1N1 PANDEMIC -- EBOLA -- COVID-19 -- ORIGIN OF CORONAVIRUS -- TYPES OF CORONAVIRUSES -- DISEASE ASSOCIATED WITH CORONAVIRUSES -- MURINE HEPATITIS VIRUS (MHV) -- Central Nervous System -- Hepatitis -- Pneumonitis -- BOVINE CORONAVIRUS -- HUMAN CORONAVIRUS -- ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Chapter 2 -- Hitesh Malhotra1,*, Anjoo Kamboj1 and Peeyush Kaushik1 -- INTRODUCTION -- GENOMIC STRUCTURE OF CORONAVIRUS -- STRUCTURAL PROTEINS -- Spike Protein -- Small Membrane Protein -- Membrane Protein -- Hemagglutinin-Esterase -- Nucleocapsid and Internal Proteins -- Replicase Protein -- VIRAL CYCLE -- OUTBREAKS OF CORONAVIRUS -- Porcine Coronavirus -- Avian Coronavirus -- Feline Coronavirus -- Bovine Coronavirus -- Murine Coronavirus -- Human Coronavirus -- SARS-CoV -- MERS-CoV -- COVID-19 -- Introduction -- Chronology of COVID-19 -- Symptoms -- Transmission -- Treatment -- LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Chapter 3 -- Kamya Goyal1,2,#, Shammy Jindal1,#, Tarun Kumar3, Jugnu Goyal4, Reena Sharma5, Ravinder Singh6 and Samir Mehndiratta7,8,* -- INTRODUCTION -- GEOGRAPHICAL DISTRIBUTION -- GLOBAL EPIDEMIOLOGY OF COVID-19 -- Effect of Age, Sex and other Factors on Covid-19-Related Deaths -- COVID-19 CASE COMPARISONS IN DIFFERENT REGION OF WORLD (WORLD HEALTH ORGANIZATION, 2020) -- COVID-19 IN INDIA -- REPORT BY ICMR ON COVID-19 ABOUT CONTAINMENT ZONE IN INDIA -- NATIONAL RESPONSES ON COVID-19 WORLDWIDE.
Asia -- China -- South Korea -- Middle Eastern -- Iran -- Europe -- Spain -- France -- North America -- United States -- South America -- Africa -- Oceania -- EFFECT OF LOCKDOWN ON COVID-19 CASES IN TOP TEN MOST AFFECTED COUNTRIES OF WORLD -- THE ROLE OF WHO AND INGOS FOR PROVIDING DATA IN COVID-19 -- OUTCOMES FROM SOME PUBLISHED REPORTS ON COVID-19 EPIDEMIOLOGY -- Herd Immunity-COVID-19 -- CONCLUSION -- LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Chapter 4 -- Anirban Ghosh1 and Shamsher Singh1,* -- INTRODUCTION -- TRANSMISSION OF COV -- Virus Life Cycle -- Role of Structural Proteins in The Pathogenesis -- A. Spike Protein -- B. Hemagglutinin-Esterase (HE) Protein -- C. Membrane (M) Protein -- D. Small Envelop (E) Protein -- E. Nucleocapsid (N) Protein and Internal (I) Protein -- F. Replicase Proteins -- G. CoV Associated Protein -- Pathophysiology from a Cell Biology Perspective -- Phase I. Asymptomatic Stage (First 1-2 Days of Infection) -- Phase II. Upper Airway and Conducting Airway Response (Next Few Days) -- Phase III. Hypoxia, Ground-glass Infiltrates, Progression to ARDs -- CONCLUSION -- LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Chapter 5 -- Jasleen Kaur1, Baljinder Singh2, Bikash Medhi3 and Gurpreet Kaur1,* -- INTRODUCTION -- CLINICAL PRESENTATIONS OF COVID-19 INFECTION -- INTER-INDIVIDUAL VARIATIONS IN CLINICAL PRESENTATIONS DUE TO DIFFERENTIAL SUSCEPTIBILITY TOWARDS COVID-19 -- Neonates or Newborns (Upto 1 Month) -- Infants (1 Month-2 Years), Children (2-10 Years) -- Adolescent (11-19 Years), Young (20-35 Years) and Middle Aged (36-59 Years) Patients -- Elderly (> -- 60 Years) and Older (> -- 80 Years) Patients -- ACE2 -- Gender -- Blood Group -- Previous Immunization -- COMORBIDITY -- CONCLUSION. LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Chapter 6 -- Richa Deshpande1,#, Aishwarya Joshi1,#, Nikunj Tandel1 and Rajeev K. Tyagi2,* -- COVID-19: A PANDEMIC DISEASE -- COVID-19: EARLY DETECTION BASED ON SYMPTOMS -- Clinical Analysis -- Hematological Analysis -- Chest CT -- COVID-19: MOLECULAR DETECTION OF VIRUS -- RT-PCR Based Assays -- Loop Mediated Isothermal Amplification (LAMP) -- CRISPR-Isothermal Amplification Based Assays -- Microarrays -- Metagenomic Sequencing Based Methods -- Gold Nanoparticles-Based Colorimetric Assay -- COVID-19: SERIOLOGICAL AND IMMUNOLOGICAL BASED DETECTION -- BIOMARKER IDENTIFICATION: APPROACH OF SEROLOGICAL PLATFORM -- Antibody Biomarkers -- Antigen Biomarkers -- Procalcitonin and Interleukin-6 as Prognostic COVID-19 Biomarkers -- SEROLOGICAL AND IMMUNOLOGICAL ASSAYS -- Enzyme-linked Immunosorbent Assay (ELISA) -- Lateral Flow Immunoassay -- Neutralization Assays -- Luminescence-based Immunoassays -- Biosensor Tests -- Rapid Antigen Tests -- CONCLUDING REMARKS -- LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Subject Index. |
Altri titoli varianti | COVID-19 |
Record Nr. | UNINA-9910794540303321 |
Mittal Neeraj
![]() |
||
Sharjah : , : Bentham Science Publishers, , 2021 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
COVID-19 |
Autore | Mittal Neeraj |
Edizione | [1st ed.] |
Pubbl/distr/stampa | Sharjah : , : Bentham Science Publishers, , 2021 |
Descrizione fisica | 1 online resource (223 pages) |
Disciplina | 616.2414 |
Altri autori (Persone) |
BhadadaSanjay K
KatareO. P |
Soggetto topico |
COVID-19 (Disease) - Prevention
COVID-19 (Disease) - Economic aspects COVID-19 (Disease) - Social aspects COVID-19 Pandemic, 2020- |
Soggetto non controllato |
Communicable Diseases
Medical |
ISBN | 1-68108-808-8 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Foreword -- Preface -- List of Contributors -- Chapter 1 -- Sunishtha1, Govind Singh1 and Sanju Nanda1,* -- INTRODUCTION -- THE ATHENIAN PLAGUE -- PLAGUE OF JUSTINIAN -- THE BLACK DEATH -- SPANISH FLU -- AIDS -- SMALLPOX -- SARS -- SWINE FLU OR H1N1 PANDEMIC -- EBOLA -- COVID-19 -- ORIGIN OF CORONAVIRUS -- TYPES OF CORONAVIRUSES -- DISEASE ASSOCIATED WITH CORONAVIRUSES -- MURINE HEPATITIS VIRUS (MHV) -- Central Nervous System -- Hepatitis -- Pneumonitis -- BOVINE CORONAVIRUS -- HUMAN CORONAVIRUS -- ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Chapter 2 -- Hitesh Malhotra1,*, Anjoo Kamboj1 and Peeyush Kaushik1 -- INTRODUCTION -- GENOMIC STRUCTURE OF CORONAVIRUS -- STRUCTURAL PROTEINS -- Spike Protein -- Small Membrane Protein -- Membrane Protein -- Hemagglutinin-Esterase -- Nucleocapsid and Internal Proteins -- Replicase Protein -- VIRAL CYCLE -- OUTBREAKS OF CORONAVIRUS -- Porcine Coronavirus -- Avian Coronavirus -- Feline Coronavirus -- Bovine Coronavirus -- Murine Coronavirus -- Human Coronavirus -- SARS-CoV -- MERS-CoV -- COVID-19 -- Introduction -- Chronology of COVID-19 -- Symptoms -- Transmission -- Treatment -- LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Chapter 3 -- Kamya Goyal1,2,#, Shammy Jindal1,#, Tarun Kumar3, Jugnu Goyal4, Reena Sharma5, Ravinder Singh6 and Samir Mehndiratta7,8,* -- INTRODUCTION -- GEOGRAPHICAL DISTRIBUTION -- GLOBAL EPIDEMIOLOGY OF COVID-19 -- Effect of Age, Sex and other Factors on Covid-19-Related Deaths -- COVID-19 CASE COMPARISONS IN DIFFERENT REGION OF WORLD (WORLD HEALTH ORGANIZATION, 2020) -- COVID-19 IN INDIA -- REPORT BY ICMR ON COVID-19 ABOUT CONTAINMENT ZONE IN INDIA -- NATIONAL RESPONSES ON COVID-19 WORLDWIDE.
Asia -- China -- South Korea -- Middle Eastern -- Iran -- Europe -- Spain -- France -- North America -- United States -- South America -- Africa -- Oceania -- EFFECT OF LOCKDOWN ON COVID-19 CASES IN TOP TEN MOST AFFECTED COUNTRIES OF WORLD -- THE ROLE OF WHO AND INGOS FOR PROVIDING DATA IN COVID-19 -- OUTCOMES FROM SOME PUBLISHED REPORTS ON COVID-19 EPIDEMIOLOGY -- Herd Immunity-COVID-19 -- CONCLUSION -- LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Chapter 4 -- Anirban Ghosh1 and Shamsher Singh1,* -- INTRODUCTION -- TRANSMISSION OF COV -- Virus Life Cycle -- Role of Structural Proteins in The Pathogenesis -- A. Spike Protein -- B. Hemagglutinin-Esterase (HE) Protein -- C. Membrane (M) Protein -- D. Small Envelop (E) Protein -- E. Nucleocapsid (N) Protein and Internal (I) Protein -- F. Replicase Proteins -- G. CoV Associated Protein -- Pathophysiology from a Cell Biology Perspective -- Phase I. Asymptomatic Stage (First 1-2 Days of Infection) -- Phase II. Upper Airway and Conducting Airway Response (Next Few Days) -- Phase III. Hypoxia, Ground-glass Infiltrates, Progression to ARDs -- CONCLUSION -- LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Chapter 5 -- Jasleen Kaur1, Baljinder Singh2, Bikash Medhi3 and Gurpreet Kaur1,* -- INTRODUCTION -- CLINICAL PRESENTATIONS OF COVID-19 INFECTION -- INTER-INDIVIDUAL VARIATIONS IN CLINICAL PRESENTATIONS DUE TO DIFFERENTIAL SUSCEPTIBILITY TOWARDS COVID-19 -- Neonates or Newborns (Upto 1 Month) -- Infants (1 Month-2 Years), Children (2-10 Years) -- Adolescent (11-19 Years), Young (20-35 Years) and Middle Aged (36-59 Years) Patients -- Elderly (> -- 60 Years) and Older (> -- 80 Years) Patients -- ACE2 -- Gender -- Blood Group -- Previous Immunization -- COMORBIDITY -- CONCLUSION. LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Chapter 6 -- Richa Deshpande1,#, Aishwarya Joshi1,#, Nikunj Tandel1 and Rajeev K. Tyagi2,* -- COVID-19: A PANDEMIC DISEASE -- COVID-19: EARLY DETECTION BASED ON SYMPTOMS -- Clinical Analysis -- Hematological Analysis -- Chest CT -- COVID-19: MOLECULAR DETECTION OF VIRUS -- RT-PCR Based Assays -- Loop Mediated Isothermal Amplification (LAMP) -- CRISPR-Isothermal Amplification Based Assays -- Microarrays -- Metagenomic Sequencing Based Methods -- Gold Nanoparticles-Based Colorimetric Assay -- COVID-19: SERIOLOGICAL AND IMMUNOLOGICAL BASED DETECTION -- BIOMARKER IDENTIFICATION: APPROACH OF SEROLOGICAL PLATFORM -- Antibody Biomarkers -- Antigen Biomarkers -- Procalcitonin and Interleukin-6 as Prognostic COVID-19 Biomarkers -- SEROLOGICAL AND IMMUNOLOGICAL ASSAYS -- Enzyme-linked Immunosorbent Assay (ELISA) -- Lateral Flow Immunoassay -- Neutralization Assays -- Luminescence-based Immunoassays -- Biosensor Tests -- Rapid Antigen Tests -- CONCLUDING REMARKS -- LIST OF ABBREVIATIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES -- Subject Index. |
Altri titoli varianti | COVID-19 |
Record Nr. | UNINA-9910817553703321 |
Mittal Neeraj
![]() |
||
Sharjah : , : Bentham Science Publishers, , 2021 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
COVID-19 : respuestas desde la ingeniería y la inteligencia artificial / / Christian Salamea Palacios |
Autore | Salamea Palacios Christian |
Pubbl/distr/stampa | Brasília : , : Editorial Abya-Yala, , 2022 |
Descrizione fisica | 1 online ressource (153 pages) : illustrations |
Disciplina | 610.2 |
Soggetto topico | Medical errors - Prevention |
ISBN | 9978-10-818-1 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | por |
Altri titoli varianti | COVID-19 |
Record Nr. | UNINA-9910741392303321 |
Salamea Palacios Christian
![]() |
||
Brasília : , : Editorial Abya-Yala, , 2022 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
COVID-19 : Current Status and Future Prospects / / edited by Peter A. Leggat, John Frean, Lucille Blumberg |
Pubbl/distr/stampa | Basel : , : MDPI - Multidisciplinary Digital Publishing Institute, , 2023 |
Descrizione fisica | 1 online resource (354 pages) |
Disciplina | 614.592414 |
Soggetto topico | COVID-19 (Disease) |
ISBN | 3-0365-6741-0 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | COVID-19 |
Record Nr. | UNINA-9910683369103321 |
Basel : , : MDPI - Multidisciplinary Digital Publishing Institute, , 2023 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
COVID-19 : Impact on Public Health and Healthcare / / edited by Kavita Batra, Manoj Sharma |
Pubbl/distr/stampa | Basel, Switzerland : , : MDPI - Multidisciplinary Digital Publishing Institute, , 2022 |
Descrizione fisica | 1 online resource (133 pages) |
Disciplina | 362.1962/414 |
Soggetto topico |
COVID-19 (Disease)
COVID-19 Pandemic, 2020- |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | COVID-19 |
Record Nr. | UNINA-9910674045003321 |
Basel, Switzerland : , : MDPI - Multidisciplinary Digital Publishing Institute, , 2022 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
COVID-19 : lessons learned to prepare for the next pandemic : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixteenth Congress, second session on examining COVID-19, focusing on lessons learned to prepare for the next pandemic, June 23, 2020 |
Pubbl/distr/stampa | Washington : , : U.S. Government Publishing Office, , 2022 |
Descrizione fisica | 1 online resource (iii, 92 pages) : color illustration |
Collana | S. hrg. |
Soggetto topico |
COVID-19 Pandemic, 2020- - United States
COVID-19 (Disease) - Government policy - United States Pandemics - Government policy - United States Medical policy - United States |
Soggetto genere / forma | Legislative hearings. |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | COVID-19 |
Record Nr. | UNINA-9910717113203321 |
Washington : , : U.S. Government Publishing Office, , 2022 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
COVID-19 : update on progress toward safely getting back to work and back to school : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixteenth Congress, second session on examining COVID-19, focusing on an update on progress toward safely getting back to work and back to school, June 30, 2020 |
Pubbl/distr/stampa | Washington : , : U.S. Government Publishing Office, , 2022 |
Descrizione fisica | 1 online resource (iii, 81 pages) |
Collana | S. hrg. |
Soggetto topico |
COVID-19 Pandemic, 2020- - Social aspects - United States
COVID-19 Pandemic, 2020- - Government policy - United States COVID-19 (Disease) - Social aspects - United States COVID-19 (Disease) - Prevention - Government policy - United States Public health - United States Students - Health and hygiene - United States Industrial hygiene - United States |
Soggetto genere / forma | Legislative hearings. |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | COVID-19 |
Record Nr. | UNINA-9910717111303321 |
Washington : , : U.S. Government Publishing Office, , 2022 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
COVID-19 : efforts to increase vaccine availability and perspectives on initial implementation: report to congressional addressees |
Pubbl/distr/stampa | Washington, DC : , : United States Government Accountability Office, , 2021 |
Descrizione fisica | 1 online resource (ii, 48 pages) : illustrations |
Soggetto topico |
COVID-19 (Disease) - Vaccination - United States
COVID-19 (Disease) - Treatment - United States Vaccination - United States - Planning Vaccination - Government policy - United States Public health administration - United States Emergency management - Evaluation |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | COVID-19 |
Record Nr. | UNINA-9910717170903321 |
Washington, DC : , : United States Government Accountability Office, , 2021 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
COVID-19 : going back to college safely : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixteenth Congress, second session on examining COVID-19, focusing on going back to college safely, June 4, 2020 |
Pubbl/distr/stampa | Washington : , : U.S. Government Publishing Office, , 2021 |
Descrizione fisica | 1 online resource (iv, 119 pages) : illustration |
Collana | S. hrg. |
Soggetto topico |
COVID-19 Pandemic, 2020- - United States
COVID-19 (Disease) - United States Universities and colleges - United States |
Soggetto genere / forma | Legislative hearings. |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | COVID-19 |
Record Nr. | UNINA-9910717046703321 |
Washington : , : U.S. Government Publishing Office, , 2021 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|